Liver Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. Dec 1, 2004; 10(23): 3419-3423
Published online Dec 1, 2004. doi: 10.3748/wjg.v10.i23.3419
Table 1 Effect of PPARγ ligands on the multiplicity of DEN-induced rGST P-positive foci in male Wistar rats (mean ± SD)
Experimental groupDENDietNo. of ratsNo. of rGST P-positive foci/cm2 of liver sections
Group 1+Basal diet alone107.5 ± 3.1
Group 2+Basal diet + pioglitazone 200 ppm102.5 ± 1.2a
Group 3+Basal diet + rosiglitazone 200 ppm91.7 ± 1.1a
Group 4+Basal diet + troglitazone 1000 ppm65.6 ± 2.3a
Group 5-Basal diet alone50
Group 6-Basal diet + pioglitazone 200 ppm50
Group 7-Basal diet + rosiglitazone 200 ppm50
Group 8-Basal diet + troglitazone 1000 ppm50
Table 2 Effect of PPARγ ligands on the incidence, multiplicity, and size of DEN-induced liver tumors in male Wistar rats (mean ± SD)
Experimental groupIncidence(%)1Histology
Tumor size(mm)1
HepatocarcinomaMultiplicity0-11-2> 2
DEN + basal diet13/30 (43)250.83 ± 1.222419
DEN + pioglitazone 200 ppm5/25 (20)a80.32 ± 0.75a323a